| Patent application number | Description | Published |
|---|
| 20080299187 | Substances for Reducing Occurence of Major Cardiac Events in Humans - A medicament comprising a dispersion of Red Yeast Rice extract in Omega-3 Oils. The medicament is supplied in capsules such that a daily dose is dispensed in an integral number of capsules. A dispersant is used, preferably Lysine and bamboo. The ratio of Red Yeast Rice Extract to EPA+DHA is in the range between about 1.4 and 2.8. The medicament reduces cholesterol, triglycerides, and reduces serious heart incidents. | 12-04-2008 |
| 20090214641 | Sweetened Capsules for Administration - In an aspect of the present invention, a sweetened gelatin capsule comprises a dose and a gelatin capsule encapsulating the dose. The gelatin capsule comprises a gelatin substance, a gelatin softener, water, and a sweetener. The concentration by weight of the water in the gelatin capsule is from about 6% to about 10%. The concentration by weight of the sweetener in the gelatin capsule is from about 0.002% to about 0.003%. | 08-27-2009 |
| 20100119600 | SUBSTANCES FOR REDUCING OCCURRENCE OF MAJOR CARDIAC EVENTS COMPRISING RED YEAST RICE EXTRACT AND OMEGA-3 POLYUNSATURATED FATTY ACID OR DERIVATIVE THEREOF - Medicaments and therapeutic compositions comprise Red Yeast Rice extract and omega-3 polyunsaturated fatty acids and/or derivatives thereof, e.g., DHA, derivatives of DHA, EPA, derivatives of EPA or mixtures thereof. One source of the fatty acids or derivatives thereof is fish oil. The compositions are useful for lowering cholesterol and/or triglyceride levels in a subject. | 05-13-2010 |
| 20100215758 | EFFERVESCENT NUTRITIONAL AND/OR DIETARY SUPPLEMENT COMPOSITION - An effervescent composition is provided comprising a dry, free-flowing powder comprising (a) microcapsules comprising a hollow, solid, water soluble outer shell comprising a starch, a sugar or mixtures thereof and an inner core comprising a liquid, water immiscible oil comprising at least one polyunsaturated fatty acid, at least one derivative of a polyunsaturated fatty acid or mixtures thereof, and (b) an effervescing agent. | 08-26-2010 |
| 20100215781 | THERAPEUTIC COMPOSITION COMPRISING OMEGA-3 POLYUNSATURATED FATTY ACID OR DERIVATIVE THEREOF, RESVERATROL AND GREEN TEA - A therapeutic composition is provided comprising: (1) at least one omega-3 polyunsaturated fatty acid, at least one pharmaceutically acceptable omega-3 polyunsaturated fatty acid derivative or mixtures thereof; (2) resveratrol or a resveratrol derivative; and (3) green tea or a green tea derivative, each in an amount, individually and in combination, effective for a therapeutic, preventive or nutritional activity in a subject in need thereof. | 08-26-2010 |
| 20110217275 | COMPOSITIONS COMPRISING PROBIOTIC BACTERIA OF THE STRAIN BACILLUS COAGULANS AND OMEGA-3 POLYUNSATURATED FATTY ACIDS OR DERIVATIVES THEREOF - Medicaments and therapeutic compositions contain (1) omega-3 polyunsaturated fatty acids and/or derivatives thereof e.g., DHA, derivatives of DHA, EPA, derivatives of EPA or mixtures thereof and (2) a probiotic bacteria of the strain | 09-08-2011 |
| 20110217370 | SUBSTANCES FOR PROMOTING HEALTHY JOINT FUNCTION COMPRISING GLUCOSAMINE SULFATE, OMEGA-3 POLYUNSATURATED FATTY ACIDS OR DERIVATIVES THEREOF, AND UNDENATURED TYPE II COLLAGEN - Medicaments and therapeutic compositions contain (1) at least one omega-3 polyunsaturated fatty acid, or at least one pharmaceutically acceptable omega-3 polyunsaturated fatty acid derivative or mixtures thereof, (2) glucosamine sulfate, and (3) undenatured Type II collagen. One source of the fatty acids or derivatives thereof is fish oil. The compositions are useful for promoting joint health in a subject. | 09-08-2011 |
| 20110218151 | SUBSTANCES FOR PROMOTING HEALTHY JOINT FUNCTION COMPRISING OMEGA-3 POLYUNSATURATED FATTY ACIDS OR DRIVATIVES THEREOF, UNDENATURED TYPE II COLLAGEN AND, OPTIONALLY, GLUCOSAMINE SULFATE - Medicaments and therapeutic compositions contain (1) at least one omega-3 polyunsaturated fatty acid, or at least one pharmaceutically acceptable omega-3 polyunsaturated fatty acid derivative or mixtures thereof, (2) undenatured Type II collagen and, optionally, (3) glucosamine sulfate. One source of the fatty acids or derivatives thereof is fish oil. The compositions are useful for promoting joint health in a subject. | 09-08-2011 |
